Neogenomics Inc. Files 2024 10-K
Ticker: NEO · Form: 10-K · Filed: Feb 18, 2025 · CIK: 1077183
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
NEO filed its 2024 10-K. Financials and operations detailed.
AI Summary
Neogenomics Inc. filed its 2024 10-K on February 18, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Nevada and headquartered in Fort Myers, Florida, operates in the testing laboratories sector. This filing provides a comprehensive overview of the company's financial performance and operational status for the year.
Why It Matters
This 10-K filing provides investors and stakeholders with a detailed look at Neogenomics' financial health and strategic direction for the fiscal year 2024, influencing investment decisions.
Risk Assessment
Risk Level: medium — The filing is a standard annual report and does not inherently indicate new risks beyond those typical for a publicly traded company.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-02-18 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- NEOGENOMICS INC (company) — Filer
- 0001077183 (company) — Central Index Key
- Fort Myers, FL (location) — Headquarters
- 2024-12-31 (date) — Fiscal Year End
- 2025-02-18 (date) — Filing Date
FAQ
What is Neogenomics Inc.'s primary business activity?
Neogenomics Inc. operates in the Services-Testing Laboratories sector, with SIC code 8734.
When did Neogenomics Inc. change its former name?
The company formerly known as AMERICAN COMMUNICATIONS ENTERPRISES INC changed its name to NEOGENOMICS INC on January 20, 1999.
What is the SEC file number for Neogenomics Inc.?
The SEC file number for Neogenomics Inc. is 001-35756.
In which state is Neogenomics Inc. incorporated?
Neogenomics Inc. is incorporated in Nevada (NV).
What is the business address of Neogenomics Inc.?
The business address is 9490 NEOGENOMICS WAY, FORT MYERS, FL 33912.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 18, 2025 regarding NEOGENOMICS INC (NEO).